Bausch Health's Salix Scholarship: Empowering GI Patients and Enhancing Brand Reputation

Bausch Health Companies Inc. (NYSE/TSX: BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, have announced the opening of the 2025 Salix Gastrointestinal Health Scholars Program. This initiative, now in its sixth consecutive year, aims to provide financial support to ten exceptional students living with GI diseases as they pursue their higher education goals. The program aligns with Bausch Health's broader corporate social responsibility (CSR) initiatives, demonstrating the company's commitment to supporting communities and individuals affected by GI diseases.

The Salix Gastrointestinal Health Scholars Program offers scholarships of up to $10,000 each to students attending two- or four-year colleges, universities, or advanced vocational/technical schools for the 2025-2026 academic year. The scholarships are available in three categories: Undergraduate Scholar Awards, Graduate Scholar Awards, and Working and/or Single Parents Scholar Awards. To be eligible, applicants must complete an online application, submit letters of reference, and write an essay on the impact of their diagnosed GI condition on their life and the role of their healthcare provider in managing their condition.

By offering this scholarship program, Bausch Health is not only providing financial assistance to students with GI diseases but also fostering a more inclusive and diverse workforce in the healthcare industry. The program helps to create a pipeline of highly qualified professionals who can better understand and serve the needs of patients with GI diseases, ultimately leading to improved patient care and a more efficient healthcare system.

Moreover, the Salix Gastrointestinal Health Scholars Program contributes to Bausch Health's reputation and brand perception as a socially responsible and caring organization. By investing in the education of individuals living with GI diseases, the company is demonstrating its commitment to supporting the GI community and fostering a positive image among the public, healthcare providers, and potential employees. This can lead to increased brand loyalty, trust, and goodwill, ultimately strengthening Bausch Health's brand perception in the market.

In conclusion, the Salix Gastrointestinal Health Scholars Program is an essential component of Bausch Health's broader CSR initiatives, empowering GI patients and enhancing the company's reputation and brand perception. By investing in the education of students living with GI diseases, Bausch Health is fostering a more inclusive and diverse workforce in the healthcare industry and contributing to the development of a skilled and knowledgeable workforce in the GI healthcare sector.